These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15770057)

  • 1. No effects of ozonated autohemotherapy on inflammation response in hemodialyzed patients.
    Tylicki L; Biedunkiewicz B; Rachon D; Nieweglowski T; Hak L; Chamienia A; Debska-Slizien A; Aleksandrowicz E; Mysliwska J; Rutkowski B
    Mediators Inflamm; 2004 Dec; 13(5-6):377-80. PubMed ID: 15770057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fistula function and dialysis adequacy during ozonotherapy in chronically hemodialyzed patients.
    Tylicki L; Biedunkiewicz B; Nieweglowski T; Grabowska M; Chamienia A; Slizien AD; Rutkowski B
    Artif Organs; 2004 May; 28(5):513-7. PubMed ID: 15156869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy of ozonated autohemotherapy in hemodialyzed patients with intermittent claudication: an oxygen-controlled study.
    Biedunkiewicz B; Tylicki L; Nieweglowski T; Burakowski S; Rutkowski B
    Int J Artif Organs; 2004 Jan; 27(1):29-34. PubMed ID: 14984181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood coagulation unaffected by ozonated autohemotherapy in patients on maintenance hemodialysis.
    Biedunkiewicz B; Lizakowski S; Tylicki L; Skiboeska A; Nieweglowski T; Chamienia A; Debska-Slizien A; Rutkowski B
    Arch Med Res; 2006 Nov; 37(8):1034-7. PubMed ID: 17045123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cell activity unaffected by ozonated autohemotherapy in patients with end-stage renal disease on maintenance renal replacement therapy.
    Biedunkiewicz B; Tylicki L; Rachon D; Hak L; Nieweglowski T; Chamienia A; Debska-Slizien A; Mysliwska J; Rutkowski B
    Int J Artif Organs; 2004 Sep; 27(9):766-71. PubMed ID: 15521216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of ozonated autohemotherapy on oxidative stress in hemodialyzed patients with atherosclerotic ischemia of lower limbs.
    Tylicki L; Nieweglowski T; Biedunkiewicz B; Chamienia A; Debska-Slizien A; Aleksandrowicz E; Lysiak-Szydlowska W; Rutkowski B
    Int J Artif Organs; 2003 Apr; 26(4):297-303. PubMed ID: 12757028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial clinical effects of ozonated autohemotherapy in chronically dialysed patients with atherosclerotic ischemia of the lower limbs--pilot study.
    Tylicki L; Niew głowski T; Biedunkiewicz B; Burakowski S; Rutkowski B
    Int J Artif Organs; 2001 Feb; 24(2):79-82. PubMed ID: 11256512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ozonated autohemotherapy in patients on maintenance hemodialysis: influence on lipid profile and endothelium.
    Tylicki L; Biedunkiewicz B; Nieweglowski T; Chamienia A; Slizien AD; Luty J; Lysiak-Szydlowska W; Rutkowski B
    Artif Organs; 2004 Feb; 28(2):234-7. PubMed ID: 14961966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-18 is involved in vascular injury in end-stage renal disease patients.
    Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
    Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can the combination of localized "proliferative therapy" with "minor ozonated autohemotherapy" restore the natural healing process?
    Gracer RI; Bocci V
    Med Hypotheses; 2005; 65(4):752-9. PubMed ID: 15951134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the biological effects of ozone: 11. Release of factors from human endothelial cells.
    Valacchi G; Bocci V
    Mediators Inflamm; 2000; 9(6):271-6. PubMed ID: 11213910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of C-reactive protein and interleukin-6 in plasma of patients with aggressive periodontitis.
    Sun XJ; Meng HX; Shi D; Xu L; Zhang L; Chen ZB; Feng XH; Lu RF; Ren XY
    J Periodontal Res; 2009 Jun; 44(3):311-6. PubMed ID: 18842114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects on inflammatory and nutritional markers of haemodiafiltration with online regeneration of ultrafiltrate (HFR) vs online haemodiafiltration: a cross-over randomized multicentre trial.
    Panichi V; Manca-Rizza G; Paoletti S; Taccola D; Consani C; Filippi C; Mantuano E; Sidoti A; Grazi G; Antonelli A; Angelini D; Petrone I; Mura C; Tolaini P; Saloi F; Ghezzi PM; Barsotti G; Palla R
    Nephrol Dial Transplant; 2006 Mar; 21(3):756-62. PubMed ID: 16303780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro effects of simvastatin on inflammatory markers in pre-dialysis patients.
    Panichi V; Paoletti S; Mantuano E; Manca-Rizza G; Filippi C; Santi S; Taccola D; Donadio C; Tramonti G; Innocenti M; Casto G; Consani C; Sbragia G; Franzoni F; Galetta F; Panicucci E; Barsotti G
    Nephrol Dial Transplant; 2006 Feb; 21(2):337-44. PubMed ID: 16249194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ozone therapy for patients with COVID-19 pneumonia: Preliminary report of a prospective case-control study.
    Hernández A; Viñals M; Pablos A; Vilás F; Papadakos PJ; Wijeysundera DN; Bergese SD; Vives M
    Int Immunopharmacol; 2021 Jan; 90():107261. PubMed ID: 33310665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
    Malindretos P; Sarafidis PA; Rudenco I; Raptis V; Makedou K; Makedou A; Grekas DM
    Am J Nephrol; 2007; 27(6):572-9. PubMed ID: 17804904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased peripheral circulating inflammatory cells and plasma inflammatory markers in patients with variant angina.
    Li JJ; Zhang YP; Yang P; Zeng HS; Qian XW; Zhang CY; Zhu CG; Li J; Nan JL
    Coron Artery Dis; 2008 Aug; 19(5):293-7. PubMed ID: 18607165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Source of inflammatory markers in patients with atrial fibrillation.
    Liuba I; Ahlmroth H; Jonasson L; Englund A; Jönsson A; Säfström K; Walfridsson H
    Europace; 2008 Jul; 10(7):848-53. PubMed ID: 18523031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of levels of inflammatory markers and hemostatic factors in the patients with and without peripheral arterial disease.
    Unlü Y; Karapolat S; Karaca Y; Kiziltunç A
    Thromb Res; 2006; 117(4):357-64. PubMed ID: 15890391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation and Chlamydia pneumoniae infection correlate with the severity of peripheral arterial disease.
    Kaperonis EA; Liapis CD; Kakisis JD; Dimitroulis D; Papavassiliou VG; Perrea D; Kostakis AG
    Eur J Vasc Endovasc Surg; 2006 May; 31(5):509-15. PubMed ID: 16427340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.